TissueScan, Crohn's/Colitis cDNA Array I
SKU
CCRT501
TissueScan Crohn's and Colitis Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering both Crohn's and Colitis disease and normal tissues
$2,500.00
In Stock*
Specifications
Reviews
Documents
| Product Manuals |
| FAQs |
| SDS |
Citations
Targeting epithelial IFN-I signaling restores barrier integrity in anti-TNF refractory Crohn's disease
Gadeock, King, Polk et al
J Crohns Colitis (2026) 20 (9) DOI: 10.1093/ecco-jcc/jjag140
Gadeock, King, Polk et al
J Crohns Colitis (2026) 20 (9) DOI: 10.1093/ecco-jcc/jjag140
AI Summary: OriGene’s Human IBD cDNA 96-well plates (no. CCRT501) were used in this study to provide cDNA samples from healthy controls and IBD patients, enabling gene expression analyses that helped identify epithelial IFN-I gene signatures distinguishing anti-TNF non-responders in Crohn’s disease.
Snippet: … IBD cDNA array and histological grading of parallel tissuesHuman IBD cDNA 96-well plates containing cDNA from six healthy controls, 12 UC, and 12 CD donors were obtained from OriGene Technologies (Rockville, MA, USA;no. CCRT501). …
Temporal transcriptomic profiling identifies core regulators in cytokine-induced gut barrier disruption in differentiated Caco-2 cells
Yoon, Ma, Kanke et al
Inflamm Res (2026) 75 (1) DOI: 10.1007/s00011-026-02288-5
Yoon, Ma, Kanke et al
Inflamm Res (2026) 75 (1) DOI: 10.1007/s00011-026-02288-5
AI Summary: OriGene’s Human Normal and Disease Tissue qPCR Array Panels (CCRT501 and panel II) were used in this study to provide intestinal tissue samples from both healthy and IBD (Crohn’s and colitis) patients, enabling the authors to quantify disease-relevant gene expression changes by qPCR.
Snippet: II which contain ten identical sets of 47–48 large and small intestine tissues covering both Crohn’s and colitis disease and normal tissue were purchased from Origene.;NA array panel I (CCRT501) and panel II which contain ten identical sets of 47–48 large and small intestine tissues covering both Crohn’s and colitis disease and normal tissue were purchased from Origene. …
EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness
Gimeno-Valiente, Riffo-Campos, Ayala et al
Sci Rep (2020) 10 (1), 3723 DOI: 10.1038/s41598-020-60476-7
Gimeno-Valiente, Riffo-Campos, Ayala et al
Sci Rep (2020) 10 (1), 3723 DOI: 10.1038/s41598-020-60476-7
Cited by 24
AI Summary: OriGene’s TissueScan cDNA array was used to analyze EPDR1 expression levels in colorectal cancer patient samples, enabling the authors to demonstrate significant up-regulation of EPDR1 in tumor tissues compared to normal mucosa.
Snippet: S1. EPDR1 is up-regulated in human CRC patients. EPDR1 expression was first analysed in a TissueScan cDNA array (OriGene) of human CRC patients (see Material and Methods). The level of whole EPDR1 and of its isoform 2 was determined by RT-qPCR in all
Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells
Koon, Shih, Hing et al
Am. J. Pathol. (2011) 179 (5), 2315-26 DOI: 10.1016/j.ajpath.2011.07.038
Koon, Shih, Hing et al
Am. J. Pathol. (2011) 179 (5), 2315-26 DOI: 10.1016/j.ajpath.2011.07.038
Cited by 17
Showing 1-4 of 4 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
